Main > INFECTIOUS DISEASES > USA. P. COVID-19>Treat>Nirmatrelvi+



USA. P. COVID-19>Treat>Nirmatrelvi+'s subsections
(*) USA Approval Date: 2023. 05.25
+ Ritonavir Tablets
Company
TM
TM Web-Site
WIPO Number

USA. P. COVID-19>Treat>Nirmatrelvi+'s products
This section has no products